Final briefs submitted in administrative hearings on marijuana rescheduling as the DEA and opponents clash over federal evaluation processes.

Democratic candidate James Talarico eyes collaboration with Donald Trump on federal marijuana legalization and record expungement.

A majority of U.S. military veterans support legalizing cannabis for recreational and medical use, a 2026 veterans survey finds—impacting policy debates in DC, Maryland, and Virginia.

Anti-marijuana groups and a pharma company asked a D.C. appeals court to revive their challenge to a Medicare initiative that lets providers furnish certain hemp-derived CBD products to beneficiaries.

A White House move to shift marijuana from Schedule I to Schedule III could ease taxes and research hurdles—but it won’t legalize sales or delivery overnight.

A new GAO report says DEA and FDA lack clear drug-scheduling procedures just as an ALJ reviews moving cannabis to Schedule III and court fights continue.

A D.C. Circuit panel declined to pause AG Todd Blanche’s move placing certain marijuana activity in Schedule III, leaving the framework in effect while challenges proceed.

A legal challenge targeting federal medical marijuana rescheduling survived its initial hurdle, setting up the next phase of policy uncertainty.